Angelo, Gordon & Co »

Halozyme Therapeutics shares owned by Angelo, Gordon & Co

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Angelo, Gordon & Co from 13F filings

Historical chart of Angelo, Gordon & Co investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Angelo, Gordon & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Angelo, Gordon & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.7M 5.0M 1.14

More positions owned by Angelo, Gordon & Co

Realogy Hldgs (HOUS)
Evergy Note 4.500%12/1
Starwood Ppty Tr Note 6.750% 7/1
Bofa Fin MTNF 0.600% 5/2
Ugi Corp Note 5.000% 6/0
Wec Energy Group Note 4.375% 6/0
Hewlett Packard Enterprise C 7.625 Mand Conv (HPE.PC)
Southern Note 4.500% 6/1
Pg&e Corp Note 4.250%12/0
Marriott Vacations Worldwide Note 3.250%12/1
Kkr & Co 6.25 Con Ser D (KKR.PD)
American Wtr Cap Corp Note 3.625% 6/1
Pg&e Corp Pfd Conv Ser A (PCG.PX)
Anywhere Real Estate Group L Note 0.250% 6/1
Pinnacle West Cap Corp Note 4.750% 6/1

View all positions for Angelo, Gordon & Co

Top funds holding Halozyme Therapeutics

Steelhead Partners
Opti Capital Management
Linden Advisors
Millennium Management
MacKay Shields
DeepCurrents Investment Group
Tenor Capital Management
BlackRock
Lazard Asset Management
M&G
Calamos Advisors
Wellesley Investment Advisors
UBS O'Connor
Jpmorgan Chase & Co
State Street Corporation

View all funds holding Halozyme Therapeutics